These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
401 related articles for article (PubMed ID: 31805975)
1. Treatment of consistent BRAF/HRAS gene mutation and MYC amplification radiation-induced abdominal wall angiosarcoma with low-dose apatinib: a case report. Guan J; Luo Z; Xiao Z; Xie Y; Lin L BMC Cancer; 2019 Dec; 19(1):1188. PubMed ID: 31805975 [TBL] [Abstract][Full Text] [Related]
2. Apatinib treatment for KIT- and KDR-amplified angiosarcoma: a case report. Yang L; Liu L; Han B; Han W; Zhao M BMC Cancer; 2018 May; 18(1):618. PubMed ID: 29855279 [TBL] [Abstract][Full Text] [Related]
3. [18F-FDG PET/CT contributes to diagnostics and therapy monitoring of radiation-induced angiosarcoma]. Cucchi F; Bülow J; Simonsen L; Nedergaard L; Haarmark C; Asmar A Ugeskr Laeger; 2017 Jan; 179(1):. PubMed ID: 28074770 [TBL] [Abstract][Full Text] [Related]
4. Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression. Fraga-Guedes C; André S; Mastropasqua MG; Botteri E; Toesca A; Rocha RM; Peradze N; Rotmensz N; Viale G; Veronesi P; Gobbi H Breast Cancer Res Treat; 2015 May; 151(1):131-40. PubMed ID: 25893585 [TBL] [Abstract][Full Text] [Related]
5. Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases. Mentzel T; Schildhaus HU; Palmedo G; Büttner R; Kutzner H Mod Pathol; 2012 Jan; 25(1):75-85. PubMed ID: 21909081 [TBL] [Abstract][Full Text] [Related]
6. Apatinib, combined with chemotherapy or alone is effective in treating angiosarcoma: a case report. Liu M; Liu Y; Guo H; Fu D; Lv L; Chen C; Li Y; Zhang W; Yao M; Zhao L Anticancer Drugs; 2019 Aug; 30(7):e0738. PubMed ID: 31305298 [TBL] [Abstract][Full Text] [Related]
7. Fully automated dual-color dual-hapten silver in situ hybridization staining for MYC amplification: a diagnostic tool for discriminating secondary angiosarcoma. Ko JS; Billings SD; Lanigan CP; Buehler D; Fernandez AP; Tubbs RR J Cutan Pathol; 2014 Mar; 41(3):286-92. PubMed ID: 24329959 [TBL] [Abstract][Full Text] [Related]
8. Radiation-induced breast angiosarcoma with a confirmative feature of c-MYC amplification. Tajima S; Mochizuki R; Sugimura H; Hoshi S Jpn J Clin Oncol; 2014 Jul; 44(7):702-3. PubMed ID: 24903854 [No Abstract] [Full Text] [Related]
9. Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions. Guo T; Zhang L; Chang NE; Singer S; Maki RG; Antonescu CR Genes Chromosomes Cancer; 2011 Jan; 50(1):25-33. PubMed ID: 20949568 [TBL] [Abstract][Full Text] [Related]
10. FISH for MYC amplification and anti-MYC immunohistochemistry: useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferations. Fernandez AP; Sun Y; Tubbs RR; Goldblum JR; Billings SD J Cutan Pathol; 2012 Feb; 39(2):234-42. PubMed ID: 22121953 [TBL] [Abstract][Full Text] [Related]
11. Radiation-associated cutaneous atypical vascular lesions and angiosarcoma: clinicopathologic analysis of 42 cases. Brenn T; Fletcher CD Am J Surg Pathol; 2005 Aug; 29(8):983-96. PubMed ID: 16006792 [TBL] [Abstract][Full Text] [Related]
12. Radiation-induced laryngeal angiosarcoma after cervical tuberculosis and squamous cell carcinoma: case report and review of the literature. Miura K; Kum Y; Han G; Tsutsui Y Pathol Int; 2003 Oct; 53(10):710-5. PubMed ID: 14516323 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of MYC amplification and anti-MYC immunohistochemistry in atypical vascular lesions, primary or radiation-induced mammary angiosarcomas, and primary angiosarcomas of other sites. Ginter PS; Mosquera JM; MacDonald TY; D'Alfonso TM; Rubin MA; Shin SJ Hum Pathol; 2014 Apr; 45(4):709-16. PubMed ID: 24457083 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical and Fluorescence In Situ Hybridization Analysis of MYC in a Series of 17 Cutaneous Angiosarcomas: A Single-Center Study. Requena C; Rubio L; Lavernia J; Machado I; Llombart B; Sanmartín O; Traves V; Guillén C; Cruz J Am J Dermatopathol; 2018 May; 40(5):349-354. PubMed ID: 29135507 [TBL] [Abstract][Full Text] [Related]
15. Development of RET mutant cutaneous angiosarcoma during BRAF inhibitor therapy. Dai J; Kunder CA; Chu EY; Chan EF; Egan CL; Novoa RA J Cutan Pathol; 2017 Dec; 44(12):1053-1056. PubMed ID: 28796396 [TBL] [Abstract][Full Text] [Related]
16. Significant partial response of metastatic intra-abdominal and pelvic round cell liposarcoma to a small-molecule VEGFR-2 tyrosine kinase inhibitor apatinib: A case report. Dong M; Bi J; Liu X; Wang B; Wang J Medicine (Baltimore); 2016 Aug; 95(31):e4368. PubMed ID: 27495042 [TBL] [Abstract][Full Text] [Related]
17. The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation-associated angiosarcomas of the breast. Kuba MG; Xu B; D'Angelo SP; Rosenbaum E; Plitas G; Ross DS; Brogi E; Antonescu CR Histopathology; 2021 Nov; 79(5):836-846. PubMed ID: 34165212 [TBL] [Abstract][Full Text] [Related]
18. MYC and NOTCH1-positive postradiation cutaneous angiosarcoma of the breast. Sheu TG; Hunt KK; Middleton LP Breast J; 2021 Mar; 27(3):264-267. PubMed ID: 33527629 [TBL] [Abstract][Full Text] [Related]
19. [Secondary angiosarcoma of the abdominal wall after adjuvant radiotherapy in a patient with uterine carcinoma - a case report]. Zatloukal A; Lerch M; Zonča P Rozhl Chir; 2016 Mar; 95(3):131-3. PubMed ID: 27091623 [TBL] [Abstract][Full Text] [Related]
20. Secondary angiosarcoma following irradiation--case report and review of the literature. Kim MK; Huh SJ; Kim DY; Yang JH; Han J; Ahn YC; Lim DH Radiat Med; 1998; 16(1):55-60. PubMed ID: 9568635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]